EAA conventions are scheduled biannually
The EAA is planning to hold conventions with invited participants from all stakeholder groups to discuss key challenges within the European access environment.
The agenda will include both, a ‘top-down’ health policy perspective by covering key market access strategy trends as well as a ‘bottom-up’ granular HTA perspective by identifying and discussing the most heterogeneous and controversial HTA procedures across Europe.
Where feasible, conventions or individual sessions will be made accessible to a wider audience via online-streaming. Further, the proceedings of the EAA conventions will be published.
Current / Upcoming Convention
SAVE THE DATE
for the
EAA Fall Convention 2025
'EU HTA: Transitioning from Preparation to Implementation'
in Rome, Italy
on October 24 / 25, 2024
Recent Conventions
Video-recordings of the EAA Spring Convention, April 2024,
EU HTA - Finding the Right Balance
Maureen Rutten-van Mölken
(Head of HTA Department at ESHPM, Erasmus University)
Maya Matthews
(Head of Unit at DG Santé, European Commission)
Bernhard Wörmann
(Medical Superintendant at DGHO & Charité University Medicine)
Antonella Cardone
(CEO at Cancer Patients Europe)
Maiwenn Al
(HTA Department at ESHPM, Erasmus University)
Stefan Lange
(former Deputy Head at IQWiG)
Francesco Pignatti
(Scientific Advisor for Oncology at EMA)
Elisabeth de Vries
(Cancer Medicines Committee & MCBS Working Group at ESMO)
Laetitia Mariani
(HTA Collaborations Lead at Abbvie)
Panel Discussion
(B. Wörmann, A. Cardone, M. Al, S. Lange, F. Pignatti, E. de Vries, L. Mariani)
Carin Uyl-de Groot
(HTA Department at ESHPM, Erasmus University)
Michael Ermisch
(Head of Department AMNOG G-BA at GKV-SV
Video-recordings of the EAA Fall Convention, October 2023,
Haemato- / Oncology - A Pace Maker for EU HTA:
Caroline Pothet
(Head of Advanced Therapies and Haematological Diseases at EMA)
Roisin Adams
(Chair of the HTA Coordination Group)
Elisabeth de Vries
(Cancer Medicines Committee & MCBS Working Group at ESMO)
César Hernández García
(Director General of Common NHS Portfolio and Pharmacy, Ministry of Health Spain)
Martin Kaiser
(European Hematology Association)
Bernhard Wörmann
(Medical Superintendant at German Society for Hematology and Oncology
(DGHO))
Brian Cuffel
(VP & Head of Market Access Oncology at Bayer Pharmaceuticals)
Panel Discussion:
(C. Pothet, R. Adams, E. de Vries, M. Kaiser, B. Wörmann, B. Cuffel; O. Solà-Morales, J. Ruof)
Video-recordings of the EAA Spring Convention, April 2023,
Midterms & Status of the Preparation Phase of the EU HTA Regulation:
Maya Matthews
(Head of Unit at DG Santé, European Commission)
Michael Berntgen
(Head of Scientific Evidence Generation Department, EMA)
Valentina Strammiello
(Director of Programmes, European Patients’ Forum)
Renato Bernardini
(Professor of Pharmacology, University of Catania School of Medicine & Deputy President, AIFA)
Michal Ermisch
(Division of Pharmaceuticals, National Association of Statutory Health Insurance Funds, Germany)
Ansgar Hebborn
(Head, European Access Policy Affairs, Roche & Chair of the HTA Working Group, EFPIA)
Andrew Wilson
(Chair, Pharmaceutical Benefits Advisory Committee, Australian Department of Health and Aged Care & Co-Director, Menzies Centre for Health Policy and Economics, University of Sydney)
Panel Discussion:
(M. Matthews, M. Berntgen, V. Strammiello, R. Bernardini, M. Ermisch, A. Hebborn, A. Wilson)
Click here for the complete proceedings of past EAA Conventions.